Healthcare providers should maintain a high index of suspicion for serotonin toxicity given the increasing use of legal and illicit serotonergic drugs.
Answers are grounded in this paper and cite their sources.
Encourages vigilance for serotonin toxicity in prehospital care; leaves open prospective validation of diagnostic and management strategies.
Introduction Serotonin toxicity — or serotonin syndrome — is a potentially life threatening adverse reaction to the use of one or more serotonergic drugs. Patients presenting with low-level obscure symptoms may have pathophysiology rooted in adverse dopamine and serotonergic poly-pharmacy reactions involving illegal, over-the-counter and/or prescription drugs. Aim This paper presents an overview of serotonin toxicity, the criteria for diagnosing serotonin toxicity, and discusses management strategies. Conclusion Due to the increasing prevalence of serotonergic drugs, both legal and illicit, a high index of suspicion for serotonin toxicity across a broad patient demographic is recommended. We also recommend education and further research to both raise awareness and advance the clinical competence of health care providers.
No takes yet. Share an insight, caveat, or question.
Rotheram et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: